Anticancer Medicine Access
The study treated NEML inclusion, registration, and local production as upstream determinants of access rather than directly measuring availability or affordability. Access to anticancer medicines in South Asia is constrained by poor coord…
1 sources - 4 claims
The study treated NEML inclusion, registration, and local production as upstream determinants of access rather than directly measuring availability or affordability. Access to anticancer medicines in South Asia is constrained by poor coordination between policy, regulation, and supply systems. Financial constraints, weak regulation, import dependence, small markets, and limited manufacturing capacity all restrict access.